CFDA: An alternative to placebo-controlled clinical trials

被引：0
|
作者：
Colbert, C [1 ]
Perelman-Hall, D [1 ]
Bachtell, R [1 ]
Bailey, J [1 ]
机构：
[1] Wright State Univ, Sch Med, Dayton, OH 45435 USA
来源：
MEDICAL PHYSICS | 2003年 / 30卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1461 / 1461
页数：1
相关论文
共 50 条
  • [21] Building in placebo-controlled trials
    Ehrlich, GE
    ANNALS OF INTERNAL MEDICINE, 2001, 134 (12) : 1150 - 1151
  • [22] MOCLOBEMIDE - PLACEBO-CONTROLLED TRIALS
    SILVERSTONE, T
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1993, 7 (3-4) : 133 - 136
  • [23] Placebo-controlled trials - Response
    Temple, R
    Ellenberg, SS
    ANNALS OF INTERNAL MEDICINE, 2001, 135 (01) : 63 - 64
  • [24] The ethics of placebo-controlled trials
    Reynolds, T
    ANNALS OF INTERNAL MEDICINE, 2000, 133 (06) : 491 - 492
  • [25] Ethics of placebo-controlled clinical trials in multiple sclerosis - A reassessment
    Polman, C. H.
    Reingold, S. C.
    Barkhof, F.
    Calabresi, P. A.
    Clanet, M.
    Cohen, J. A.
    Cutter, G. R.
    Freedman, M. S.
    Kappos, L.
    Lublin, F. D.
    McFarland, H. F.
    Metz, L. M.
    Miller, A. E.
    Montalban, X.
    O'Connor, P. W.
    Panitch, H.
    Richert, J. R.
    Petkau, J.
    Schwid, S. R.
    Sormani, M. P.
    Thompson, A. J.
    Weinshenker, B. G.
    Wolinsky, J. S.
    NEUROLOGY, 2008, 70 (13) : 1134 - 1140
  • [26] Factors that influence the outcome of placebo-controlled antidepressant clinical trials
    Niklson, IA
    Reimitz, PE
    Sennef, C
    PSYCHOPHARMACOLOGY BULLETIN, 1997, 33 (01) : 41 - 51
  • [27] Attitudes of patients with schizophrenia toward placebo-controlled clinical trials
    Hummer, M
    Holzmeister, R
    Kemmler, G
    Eder, U
    Hofer, A
    Kurzthaler, I
    Oehl, M
    Weiss, E
    Fleischhacker, WW
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (03) : 277 - 281
  • [28] Feasibility of placebo-controlled clinical trials of antipsychotic compounds in Europe
    Fleischhacker, WW
    Burns, T
    PSYCHOPHARMACOLOGY, 2002, 162 (01) : 82 - 84
  • [29] Feasibility of placebo-controlled clinical trials of antipsychotic compounds in Europe
    Wolfgang W. Fleischhacker
    Tom Burns
    Psychopharmacology, 2002, 162 : 82 - 84
  • [30] Placebo-controlled clinical trials in multiple sclerosis: Ethical considerations
    Lublin, FD
    Reingold, SC
    ANNALS OF NEUROLOGY, 2001, 49 (05) : 677 - 681
12345